Agency Forms Undergoing Paperwork Reduction Act Review

Issuing agencies

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 215 (Monday, November 9, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 215 (Monday, November 9, 2026)]
[Notices]
[Pages 70888-70889]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-22819]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-27-1359]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``National Survey of Syringe Services 
Programs (NSSSP)'' to the Office of Management and Budget (OMB) for 
review and approval. CDC previously published a ``Proposed Data 
Collection Submitted for Public Comment and Recommendations'' notice on 
June 2, 2026 to obtain comments from the public and affected agencies. 
CDC received 26 comments related to the previous notice. This notice 
serves to allow an additional 30 days for public and affected agency 
comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    The National Survey of Syringe Services Programs (NSSSP) (OMB 
Control No. 0920-1359, Exp. 1/31/2027)--Revision--National Center for 
HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for 
Disease Control and Prevention (CDC).

Background and Brief Description

    The primary purpose of the National Survey of Syringe Services 
Programs (NSSSP) is to strengthen and improve the ability of CDC and 
local and state partners to monitor and evaluate syringe services 
programs (SSPs) nationally, with the overall goal of supporting, 
sustaining, and improving SSPs nationwide and reducing infectious 
disease and other harms related to drug use. Findings from the 2022-
2025 survey successfully characterized operational characteristics and 
services, funding resources, community relations, and key operational 
successes and challenges. The 2026 survey is currently being 
implemented. Revisions are being requested to address the increasing 
number of SSPs nationwide, updated infectious disease and substance use 
prevention, testing, and treatment modalities, additional SSP services 
provided, and additional information on overdose prevention and 
reversals.
    The project will include all SSPs that are listed in a publicly 
available directory of all known SSPs in the United States maintained 
by the North American Syringe Exchange Network (NASEN; <a href="https://nasen.org">https://nasen.org</a>). The project will also include SSPs in NASEN's directory 
that do not wish to be publicly listed but have agreed to be contacted 
for research purposes, SSPs belonging to NASEN's buyers' club that are 
not part of the directory, respondents to prior RTI Arnold Ventures 
Surveys of SSPs that are not part of NASEN's directory, and other SSPs 
proactively identified through searching state health department 
websites, funding agencies, state and regional networks, regional 
conferences, partner organization networks or webinars and via social 
media.
    SSPs will be sent a letter of invitation to participate in a 35-
minute program survey. Participating programs will have the option of 
completing the survey via different modalities to enhance feasibility 
and comfort in completing the survey, for example via the Research 
Electronic Data Capture (REDCap) or a similarly secure web-based 
application. Other modalities for survey administration will include a 
coordinated telephone or videoconferencing interview. SSPs will be sent 
reminder letters for an approximately 6-month data collection period.
    The survey will include questions on operational characteristics 
and services, funding resources, community relations,

[[Page 70889]]

and key operational successes and challenges. Approximately 1000 SSPs 
will be able to participate in the survey. We anticipate that 
approximately 20% of SSPs will decline to complete the survey, yielding 
800 completed surveys per year. However, given that it is challenging 
to predict future response rates, we are requesting enough burden hours 
to allow 100% of SSPs to respond to the survey. We estimate that it 
will take 35 minutes to complete the survey, regardless of how the 
respondent chooses to complete it (i.e., self-administered online or 
interviewer-administered by phone or videoconferencing). SSPs that do 
not respond to the initial survey invitation will be given reminders to 
complete the survey over the duration of the survey implementation 
period.
    CDC requests OMB approval for an estimated 583 annualized burden 
hours. Participation of respondents is voluntary and there is no cost 
to the respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
          Type of respondents                   Form name           respondents    responses per   response  (in
                                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
All participating SSPs................  National Survey of                 1,000               1           35/60
                                         Syringe Services
                                         Programs.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2026-22819 Filed 11-6-26; 8:45 am]
BILLING CODE 4163-18-P


</pre></body>
</html>